Buy Crypto Markets Spot FuturesBTC Earn Event Center Rewards Hub

Abeona Therapeutics Inc. (ABEO)

NASDAQ

$6.01

$+0.08

(+1.35%)

Previous Close: ⁦$5.93⁩

Market Closed

Abeona Therapeutics Inc. (ABEO) Live Price Chart

Last updated: ⁦2026-09-06 04:01:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Abeona Therapeutics Inc. (ABEO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.01, with a market capitalization of $340.24M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.00 to $7.65. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$340.24M
Open	$5.89
Day's High	$568.75
Day's Low	$2.19
Previous Close	$5.93
Volume	803.15K
Average Volume	--
P/E Ratio	--
52-Week High	$7.65
52-Week Low	$4.00
Dividend Yield	--
Earnings Date	--

Abeona Therapeutics Inc. (ABEO) Latest Closing Stock Price

Abeona Therapeutics Inc. (ABEO) last closed at $5.93 as of 2026-09-04 23:31:00, unchanged from the previous close of $5.93.

During the latest regular trading session, ABEO traded between $2.19 and $568.75, with a volume of 803.15K shares. The closing price was near the lower end and near the middle of its 52-week range.

Abeona Therapeutics Inc. (ABEO) 7-Day Stock Price Change

Over the past seven days, Abeona Therapeutics Inc. (ABEO) moved from $5.91 to $6.01, representing a gain of 1.69% ($0.10).

The stock traded between $5.86 and $6.02 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 849.24 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ABEO 52-Week Price Position

Position in Range: 54.9%

52W Low$4.00

52W High$7.65

ABEO is currently trading at $6.01, placing it 54.9% of the way from its 52-week low of $4.00 to its 52-week high of $7.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Abeona Therapeutics Inc. (ABEO)?

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Abeona Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	226
Exchange	NASDAQ
Company Website	https://www.abeonatherapeutics.com

How to Buy Abeona Therapeutics Inc. (ABEO) Stock on MEXC

Eligible investors can buy real shares of Abeona Therapeutics Inc. (ABEO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ABEO and Place Your Order

Open the RealStocks trading page and search for ABEO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Abeona Therapeutics Inc. (ABEO) stock price today?

Abeona Therapeutics Inc. (ABEO) is currently trading at $ 6.01, up 1.26% ($0.08) from the previous close of $ 5.93. Intraday prices update in real time during regular trading hours.

2.Is ABEO stock going up or down today?

As of 2026-09-04 23:31:00, ABEO is trading at $ 6.01, up 1.26% ($0.08) from its previous close of $ 5.93. The stock has traded between $ 2.19 and $ 568.75 during today’s regular session. Past price movements do not guarantee future results.

3.What is ABEO pre-market price?

As of 2026-09-04 23:31:00, ABEO is trading at $ 5.93 in pre-market trading, down 0.03% ($0.00) from the previous close of $ 5.93. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ABEO after-hours price?

As of 2026-09-04 23:31:00, ABEO is trading at $ 5.98 in after-hours trading, up 0.76% ($0.04) from the regular-session close of $ 5.93. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ABEO stock trading now?

ABEO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ABEO sit relative to its 52-week high and low?

Over the past 52 weeks, ABEO has traded between a low of $ 4.00 and a high of $ 7.65. At $ 6.01, the stock is positioned 54.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Abeona Therapeutics Inc. in?

Abeona Therapeutics Inc. (ABEO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Abeona Therapeutics Inc.'s market capitalization and where is it listed?

Abeona Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 340.24M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ABEO valued in terms of P/E ratio and EPS?

ABEO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.10. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Abeona Therapeutics Inc. pay a dividend?

Abeona Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.